Ensysce Biosciences Inc (ENSC) earnings · P/E 0.0, rev $5.1M
Ensysce Biosciences Inc (ENSC) is a biotechnology company listed on US.
This ENSC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ENSC revenue for 2025-12-31 was $5.1M. Net income was -$10.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. ENSC currently screens at market cap $5.2M and trailing P/E 0.0.
When the next ENSC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 2.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ENSC research stays on the stock page; the tape stays on the quote page.
Not investment advice.